Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States
Journal of Viral Hepatitis · 2026
DOI: 10.1111/jvh.70119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2026. Verfasst von Robert J Wong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Hepatitis D, Chronic, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Hepatitis D virus (HDV) screening rates in the United States are low. We evaluated the impact of double reflex‐based HDV testing on HDV‐related morbidity and mortality in the United States. A Screen and Treat model simulated the HDV screening cascade (decision tree) and assessed the natural history of HDV (Markov model) over a 5‐year time horizon from a United States third‐party payer perspective, for patients positive for HBV. The number of patients diagnosed with HDV and liver‐related outcomes were compared under double reflex screening (100% patients screened for HDV antibodies and HDV RNA) and current practice (11% patients screened for HDV antibodies and 25% anti‐HDV‐positive patients for HDV RNA). Implementation of HDV double reflex testing predicted a 3655% increase in patients diagnosed versus current practice ( n = 7231 vs. n = 193, respectively). The number of predicted occurrences of all liver‐related outcomes over 5 years is lower with double reflex testing versus current practice (difference in numbers of events: −7% for compensated cirrhosis, −40% for decompensated cirrhosis, −23% for hepatocellular carcinoma, −34% for liver transplantation, and −32% for liver‐related deaths). Results of scenario analyses with varying HBV prevalence, treatment received, or treatment rates were similar. Simulation of double reflex testing predicted earlier detection of HDV patients, increased numbers of patients diagnosed and treated, and reduced rates of disease progression, liver‐related complications and deaths. These findings highlight the need for implementing strategies to improve HDV screening and linkage to care and treatment in the United States. Trial Registration: ClinicalTrials.gov identifier: NCT03852719
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stanford University School of Medicine, Stanford, California, USA.
- Hepatitis B Foundation, Doylestown, Pennsylvania, USA.
- New York University Grossman School of Medicine, New York, New York, USA.
- Yale School of Medicine, New Haven, Connecticut, USA.
- HEOR-Global Value and Access, Gilead Sciences, Inc., Foster City, California, USA.
- Maple Health Group, New York, New York, USA.
ORCID-Profile: Robert J Wong, Robert G Gish, Nathaniel Smith, Chong Kim
Förderung
- Gilead Sciences
Zitieren
APA
Wong, R. J., Gish, R. G., Jacobson, I. M., Lim, J. K., Rock, M., Kinyik-Merena, C., Ma, H., Smith, N., & Kim, C. (2026). Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70119
Vancouver
Wong RJ, Gish RG, Jacobson IM, Lim JK, Rock M, Kinyik-Merena C, et al. Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States. Journal of Viral Hepatitis. 2026. doi:10.1111/jvh.70119
BibTeX
@article{Wong2026,
author = {Wong, Robert J and Gish, Robert G and Jacobson, Ira M and Lim, Joseph K and Rock, Marvin and Kinyik-Merena, Csilla and Ma, Hanxiao and Smith, Nathaniel and Kim, Chong},
title = {Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States},
journal = {Journal of Viral Hepatitis},
year = {2026},
doi = {10.1111/jvh.70119}
}
EUVIMED